# Anti-PRAME Immunotherapeutic GSK2302032A

National Cancer Institute

## Source

National Cancer Institute. Anti-PRAME Immunotherapeutic GSK2302032A. NCI Thesaurus. Code C116848.

An immunotherapeutic agent targeting the tumor-associated antigen (TAA), preferentially expressed antigen of melanoma (PRAME), with potential antineoplastic activity.